Protective effects of BMSCs in combination with erythropoietin in bronchopulmonary dysplasia-induced lung injury

Zhang,Zhao‑Hua; Pan,Yan-Yan; Jing,Rui-Sheng; Luan,Yun; Zhang,Luan; Sun,Chao; Kong,Feng; Li,Kai‑Lin; Wang,Yi‑Biao

doi:10.3892/mmr.2016.5378

Protective effects of BMSCs in combination with erythropoietin in bronchopulmonary dysplasia-induced lung injury

Authors:
- Zhao‑Hua Zhang
- Yan-Yan Pan
- Rui-Sheng Jing
- Yun Luan
- Luan Zhang
- Chao Sun
- Feng Kong
- Kai‑Lin Li
- Yi‑Biao Wang
View Affiliations

Affiliations: Department of Pediatrics, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Pediatrics, Qilu Children's Hospital of Shandong University, Jinan, Shandong 066600, P.R. China, Department of Internal Medicine, Xinji Central Hospital, Changli, Hebei 250000, P.R. China, Central Research Laboratory, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
Published online on: June 8, 2016 https://doi.org/10.3892/mmr.2016.5378
Pages: 1302-1308

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bronchopulmonary dysplasia (BPD) is the most common type of chronic lung disease in infancy, for which no effective therapy is currently available. The aim of the present study was to investigate the effect of treatment with bone marrow mesenchymal stem cells (BMSCs) in combination with recombinant human erythropoietin (rHuEPO) on BPD‑induced mouse lung injury, and discuss the underlying mechanism. The BPD model was established by the exposure of neonatal mice to continuous high oxygen exposure for 14 days, following which 1x106 BMSCs and 5,000 U/kg rHuEPO were injected into the mice 1 h prior to and 7 days following exposure to hyperoxia. The animals received four treatments in total (n=10 in each group). After 14 days, the body weights, airway structure, and levels of matrix metalloproteinase‑9 (MMP‑9) and vascular endothelial growth factor (VEGF) were detected using histological and immunohistochemical analyses. The effect on cell differentiation was observed by examining the presence of platelet endothelial cell adhesion molecule (PECAM) and VEGF using immunofluorescence. Compared with the administration of BMSCs alone, the body weight, airway structure, and the levels of MMP‑9 and VEGF were significantly improved in the BMSCs/rHuEPO group. The results of the present study demonstrated that the intravenous injection of BMSCs significantly improved lung damage in the hyperoxia‑exposed neonatal mouse model. Furthermore, the injection of BMSCs in combination with intraperitoneal injection of rHuEPO had a more marked effect, compared with BMSCs alone, and the mechanism may be mediated by the promoting effects of BMSCs and EPO. The results of the present study provided information, which may assist in future clinical trials.

View Figures

View References

1	Madurga A, Miziková I, Ruiz-Camp J and Morty RE: Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 305:L893–L905. 2013. View Article : Google Scholar : PubMed/NCBI
2	Pietrzyk JJ, Kwinta P, Wollen EJ, Bik-Multanowski M, Madetko-Talowska A, Günther CC, Jagła M, Tomasik T and Saugstad OD: Gene expression profiling in preterm infants: New aspects of bronchopulmonary dysplasia development. PLoS One. 8:e785852013. View Article : Google Scholar : PubMed/NCBI
3	Warburton D, Bellusci S, De Langhe S, Del Moral PM, Fleury V, Mailleux A, Tefft D, Unbekandt M, Wang K and Shi W: Molecular mechanisms of early lung specification and branching morphogenesis. Pediatr Res. 57:R26–R37. 2005. View Article : Google Scholar
4	Thébaud B: Angiogenesis in lung development, injury and repair: Implications for chronic lung disease of prematurity. Neonatology. 91:291–297. 2007. View Article : Google Scholar : PubMed/NCBI
5	Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 33:145–152. 2005. View Article : Google Scholar : PubMed/NCBI
6	Yam J, Frank L and Roberts RJ: Oxygen toxicity: Comparison of lung biochemical responses in neonatal and adult rats. Pediatr Res. 12:115–119. 1978. View Article : Google Scholar : PubMed/NCBI
7	Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC and Stewart DJ: Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 4:e2692007. View Article : Google Scholar : PubMed/NCBI
8	Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N and Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 100:8407–8411. 2003. View Article : Google Scholar : PubMed/NCBI
9	Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S and Rojas M: Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol. 293:L131–L141. 2007. View Article : Google Scholar : PubMed/NCBI
10	Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA and Kourembanas S: Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 180:1122–1130. 2009. View Article : Google Scholar : PubMed/NCBI
11	van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J, Haromy A, Eaton F, et al: Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med. 180:1131–1142. 2009. View Article : Google Scholar : PubMed/NCBI
12	Lee JW, Fang X, Krasnodembskaya A, Howard JP and Matthay MA: Concise review: Mesenchymal stem cells for acute lung injury: Role of paracrine soluble factors. Stem Cells. 29:913–919. 2011. View Article : Google Scholar : PubMed/NCBI
13	Iosef C, Alastalo TP, Hou Y, Chen C, Adams ES, Lyu SC, Cornfield DN and Alvira CM: Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarization. Am J Physiol Lung Cell Mol Physiol. 302:L1023–L1036. 2012. View Article : Google Scholar : PubMed/NCBI
14	Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG and Elias JA: Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: A new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol. 31:650–656. 2004. View Article : Google Scholar : PubMed/NCBI
15	Jelkmann W: Erythropoietin: Structure, control of production, and function. Physiol Rev. 72:449–489. 1992.PubMed/NCBI
16	Lipsic E, Schoemaker RG, van der Meer P, Voors AA, van Veldhuisen DJ and van Gilst WH: Protective effects of erythropoietin in cardiac ischemia: From bench to bedside. J Am Coll Cardiol. 48:2161–2167. 2006. View Article : Google Scholar : PubMed/NCBI
17	King VR, Averill SA, Hewazy D, Priestley JV, Torup L and Michael-Titus AT: Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci. 26:90–100. 2007. View Article : Google Scholar : PubMed/NCBI
18	Shang Y, Li X, Prasad PV, Xu S, Yao S, Liu D, Yuan S and Feng D: Erythropoietin attenuates lung injury in lipopolysaccharide treated rats. J Surg Res. 155:104–110. 2009. View Article : Google Scholar : PubMed/NCBI
19	Ozer EA, Kumral A, Ozer E, Yilmaz O, Duman N, Ozkal S, Koroglu T and Ozkan H: Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res. 58:38–41. 2005. View Article : Google Scholar : PubMed/NCBI
20	Shang Y, Jiang YX, Xu SP, Wu Y, Wu ZY, Yuan SY and Yao SL: Reduction of pulmonary inflammatory response by erythropoietin in a rat model of endotoxaemia. Chin Med J (Engl). 122:834–838. 2009.
21	Zhang H, Fang J, Su H, Yang M, Lai W, Mai Y and Wu Y: Bone marrow mesenchymal stem cells attenuate lung inflammation of hyperoxic newborn rats. Pediatr Transplant. 16:589–599. 2012. View Article : Google Scholar : PubMed/NCBI
22	Okabe M, Ikawa M, Kominami K, Nakanishi T and Nishimune Y: 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:313–319. 1997. View Article : Google Scholar : PubMed/NCBI
23	Han X, Zhao L, Lu G, Ge J, Zhao Y, Zu S, Yuan M, Liu Y, Kong F, Xiao Z and Zhao S: Improving outcomes of acute kidney injury using mouse renal progenitor cells alone or in combination with erythropoietin or suramin. Stem Cell Res Ther. 4:742013. View Article : Google Scholar : PubMed/NCBI
24	Balasubramaniam V, Mervis CF, Maxey AM, Markham NE and Abman SH: Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: Implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 292:L1073–L1084. 2007. View Article : Google Scholar : PubMed/NCBI
25	Kunig AM, Balasubramaniam V, Markham NE, Seedorf G, Gien J and Abman SH: Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia. Am J Physiol Lung Cell Mol Physiol. 291:L1068–L1078. 2006. View Article : Google Scholar : PubMed/NCBI
26	Yang H, Xie Z, Wei L, Yang H, Yang S, Zhu Z, Wang P, Zhao C and Bi J: Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model. Stem Cell Res Ther. 4:762013. View Article : Google Scholar
27	Zhang H, Fang J, Wu Y, Mai Y, Lai W and Su H: Mesenchymal stem cells protect against neonatal rat hyperoxic lung injury. Expert Opin Biol Ther. 13:817–829. 2013. View Article : Google Scholar : PubMed/NCBI
28	Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH, Balasubramaniam V, Fredenburgh LE, Alex Mitsialis S, Kourembanas S and Kim CF: Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 302:L829–L837. 2012. View Article : Google Scholar : PubMed/NCBI
29	Abman SH and Matthay MA: Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia: Delivering the secretome. Am J Respir Crit Care Med. 180:1039–1041. 2009. View Article : Google Scholar : PubMed/NCBI
30	Hennrick KT, Keeton AG, Nanua S, Kijek TG, Goldsmith AM, Sajjam US, Bentley JK, Lama VN, Moore BB, Schumacher RE, et al: Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med. 175:1158–1164. 2007. View Article : Google Scholar : PubMed/NCBI
31	Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
32	Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S and Sharkis SJ: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105:369–377. 2001. View Article : Google Scholar : PubMed/NCBI
33	Wen ST, Chen W, Chen HL, Lai CW, Yen CC, Lee KH, Wu SC and Chen CM: Amniotic fluid stem cells from EGFP transgenic mice attenuate hyperoxia-induced acute lung injury. PLoS One. 8:e753832013. View Article : Google Scholar : PubMed/NCBI
34	Gore AV, Bible LE, Livingston DH, Mohr AM and Sifri ZC: Mesenchymal stem cells enhance lung recovery after injury, shock, and chronic stress. Surgery. 159:1430–1435. 2016. View Article : Google Scholar : PubMed/NCBI
35	Mitsialis SA and Kourembanas S: Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin Perinatol. 40:138–151. 2016. View Article : Google Scholar : PubMed/NCBI
36	Luan Y, Zhang X, Kong F, Cheng GH, Qi TG and Zhang ZH: Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism. Int Immunopharmacol. 14:432–437. 2012. View Article : Google Scholar : PubMed/NCBI
37	Buckley S and Warburton D: Dynamics of metalloproteinase-2 and -9, TGF-beta, and uPA activities during normoxic vs. hyperoxic alveolarization. Am J Physiol Lung Cell Mol Physiol. 283:L747–L754. 2002. View Article : Google Scholar : PubMed/NCBI
38	Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, Ballard PL and Truog WE: Low levels of tissue inhibitors of metalloproteinases with a high matrix metallopro-teinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics. 113:1709–1714. 2004. View Article : Google Scholar : PubMed/NCBI
39	Harijith A, Choo-Wing R, Cataltepe S, Yasumatsu R, Aghai ZH, Janér J, Andersson S, Homer RJ and Bhandari V: A role for matrix metalloproteinase 9 in IFNγ-mediated injury in developing lungs: Relevance to bronchopulmonary dysplasia. Am J Respir Cell Mol Biol. 44:621–630. 2011. View Article : Google Scholar : PubMed/NCBI
40	Abman SH: Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv Exp Med Biol. 661:323–335. 2010. View Article : Google Scholar : PubMed/NCBI
41	De Paepe ME, Mao Q, Powell J, Rubin SE, DeKoninck P, Appel N, Dixon M and Gundogan F: Growth of pulmonary microvasculature in ventilated preterm infants. Am J Respir Crit Care Med. 173:204–211. 2006. View Article : Google Scholar
42	Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C and Huyck H: Angiogenic factors and alveolar vasculature: Development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol. 282:L811–L823. 2002. View Article : Google Scholar : PubMed/NCBI
43	Hosford GE and Olson DM: Effects of hyperoxia on VEGF, its receptors and HIF-2 in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol. 285:L161–L168. 2003. View Article : Google Scholar : PubMed/NCBI
44	Acarregui MJ, Penisten ST, Goss KL, Ramirez K and Snyder JM: Vascular endothelial growth factor gene expression in human fetal lung in vitro. Am J Respir Cell Mol Biol. 20:14–23. 1999. View Article : Google Scholar
45	Le Cras TD, Markham NE, Tuder RM, Voelkel NF and Abman SH: Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol. 283:L555–L562. 2002. View Article : Google Scholar : PubMed/NCBI